Titlebook: Advances in Transplant Dermatology; Clinical and Practic Fiona Zwald,Marc D. Brown Book 2015 Springer International Publishing Switzerland

broach

書(shū)目名稱Advances in Transplant Dermatology影響因子(影響力)




書(shū)目名稱Advances in Transplant Dermatology影響因子(影響力)學(xué)科排名




書(shū)目名稱Advances in Transplant Dermatology網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Advances in Transplant Dermatology網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Advances in Transplant Dermatology被引頻次




書(shū)目名稱Advances in Transplant Dermatology被引頻次學(xué)科排名




書(shū)目名稱Advances in Transplant Dermatology年度引用




書(shū)目名稱Advances in Transplant Dermatology年度引用學(xué)科排名




書(shū)目名稱Advances in Transplant Dermatology讀者反饋




書(shū)目名稱Advances in Transplant Dermatology讀者反饋學(xué)科排名

粗俗人

Advances in Photoprotection,d cancer in Ireland (Cancer in Ireland 2013: annual report of the national cancer registry; Chapter 4.1. .). Skin cancer is therefore a preventable disease for the most part. Strategies to reduce the exposure of UVR will reduce skin cancer risk. This is of particular relevance for pale skin types, w

Incorporate

Update on Our Understanding of HPV as a Risk Factor for Cutaneous Squamous Cell Carcinoma in Organ most important risk factor for developing squamous cell carcinoma (SCC) in OTR. In the years after transplantation, OTR develop numerous warts and wart-like lesions followed by the development of SCC, which resembles the clinical picture of epidermodysplasia verruciformis patients in which human pap

逢迎春日

機(jī)制

Advances in Photodynamic Therapy for the Treatment of Malignant and Premalignant Lesions in Transplbe more numerous, diffusely located, recurrent, and aggressive in OTRs compared to immunocompetent patients. Not surprisingly, cutaneous malignancy is therefore a leading cause of morbidity and mortality in the OTR population. Given this significant disease burden, a great deal of interest has focus

stressors

,Update on Staging, Definition, and Chemoprevention of “High-Risk Squamous Cell Carcinoma” in Organ l carcinoma (SCC). In addition to increased risk of SCC development, OTRs experience a higher tumor burden, more aggressive SCCs, and increased risk of metastasis and skin cancer-related mortality, making staging, prognosis, and treatment determinations in OTR patients especially important, yet lack

阻塞

GLOOM

anticipate

Update in Melanoma in Organ Transplant Patients,eening transplant candidates to help identify a history of pretransplant melanoma or other high-risk factors for posttransplant melanoma. For those with a history of pretransplant melanoma, AJCC melanoma staging should help guide wait times prior to transplantation to ensure ethical allocation of a

Comedienne

aneous malignancies in solid organ transplant patients.WrittThis book provides an informative update on scientific advances relating to transplant dermatology that may be applicable to clinical practice. Commentary is provided on the emerging role of viruses in transplant dermatology, the management